Health Care
UK Approves Pfizer/BioNTech Coronavirus Vaccine; Inoculation To Begin Next Week
The United Kingdom became the first country in the world to approve the highly-acclaimed Pfizer/BioNTech Coronavirus vaccine.
Setting the tone for mass inoculation, the new vaccine is reported to be 95 per cent effective in protecting people from COVID-19.
Read More: Top 5 Facts About Pfizer-BioNTech’s 90%-Effective COVID-19 Vaccine
As per the BBC, the MHRA – Britain’s medicine regulator – stated that the vaccine is 95 per cent effective, and that it is safe to be rolled out.
Eight hundred thousand doses are expected to be available in the UK from next week, and people will be contacted by the NHS for inoculation.
Priority will be given to the elderly, caregivers, and NHS staff – though a rounded priority list is expected to be released soon.
Pfizer had stated earlier in November that as much as 50 million vaccines would hit the global markets before the end of this year, while another 1.3 billion will be supplied to health professionals by 2021.
Named the BNT162b2, the mRNA-based vaccine was jointly developed by American pharmaceutical company Pfizer and German biotech company BioNTech.
Sources: BBC, Pfizer
-
Dossier3 weeks agoDossier, 2026
-
Insurance2 months agoLiva Insurance Supports Community Wellness Through “Experience Oman – Muscat Marathon 2026”
-
OER Magazines2 months agoOER, January 26
-
Interviews2 months agoEXCLUSIVE INTERVIEW: TLS Rebranding Marks Strategic Leap Toward Innovation, Sustainability & Growth
-
Alamaliktistaad Magazines2 months agoAl-iktisaad, January 26
-
Banking & Finance3 weeks agoNational Finance Unveils Exclusive Ramadan Offers on Auto Financing
-
Banking & Finance3 weeks agoSohar International and Sohar Islamic Supports Over 100 Families in Al Wusta Governorate Through Its ‘Sohar Al Attaa’ Initiative
-
Banking & Finance2 months agoA New Platform for SME Growth: Oman Arab Bank Unveils Tumouhi
